2017 Annual Meeting

Area: Pharmaceutical Discovery, Development and Manufacturing Forum

Chair

Zoltan K. Nagy, Purdue University

Sessions sponsored

Amorphous Solid Dispersions for Drug Product
Sponsored by:
Co-sponsored by:
Computational Solid State Pharmaceutics
Sponsored by:
Continuous Processing Technologies Applied in Drug Product Development
Sponsored by:
Co-sponsored by:
Continuous Processing Technologies Applied in Drug Product Manufacturing
Sponsored by:
Co-sponsored by:
Continuous Processing Technologies Applied in Drug Substance Development Chemistry
Sponsored by:
Co-sponsored by:
Continuous Processing Technologies Applied in Drug Substance Development Crystallization and Drying
Sponsored by:
Co-sponsored by:
Continuous Processing Technologies Applied in Drug Substance Manufacturing
Sponsored by:
Co-sponsored by:
Critical Quality Attribute Monitoring and Control in Pharmaceutical Manufacturing I
Sponsored by:
Co-sponsored by:
Critical Quality Attribute Monitoring and Control in Pharmaceutical Manufacturing II
Sponsored by:
Co-sponsored by:
Critical Quality Attribute Monitoring and Control in Pharmaceutical Manufacturing III
Sponsored by:
Co-sponsored by:
Development of Processes and Products for Pharmaceuticals and Hybrid Therapeutics
Sponsored by:
Co-sponsored by:
Forum Plenary: Pharmaceutical Discovery, Development, and Manufacturing Forum (Invited Talks)
Sponsored by:
Co-sponsored by:
Green Pharmaceutical Process Development and Biocatalysis
Sponsored by:
Co-sponsored by:
Innovations in Biopharmaceutical Discovery, Development, and Manufacturing
Sponsored by:
Co-sponsored by:
Innovative Technologies in Pharmaceutical Discovery, Manufacturing and Delivery
Sponsored by:
Co-sponsored by:
Materials Science in Pharmaceutical Process Development I
Sponsored by:
Co-sponsored by:
Materials Science in Pharmaceutical Process Development II
Sponsored by:
Co-sponsored by:
Model Based Integrated Design of Pharmaceutical Drug Product Processes
Sponsored by:
Co-sponsored by:
Model Based Integrated Design of Pharmaceutical Drug Substance Processes I
Sponsored by:
Co-sponsored by:
Model Based Integrated Design of Pharmaceutical Drug Substance Processes II
Sponsored by:
Co-sponsored by:
Multivariate Modeling and Quality-by-Control Approaches for Pharmaceutical Processes
Sponsored by:
Co-sponsored by:
Panel: Precompetitive Collaboration
Sponsored by:
Co-sponsored by:
Particle Engineering As Applied to Pharmaceutical Formulations
Sponsored by:
Co-sponsored by:
PAT for Process Understanding, Reduced Testing, and Elucidation of Fundamental Phenomena in Drug Product/Substance Development
Sponsored by:
Co-sponsored by:
Poster Session: Pharmaceutical
Sponsored by:
Co-sponsored by:
Process Intensification and Advanced Control of Pharmaceutical Processes
Sponsored by:
Co-sponsored by:
Quality By Design in Drug Product Formulation, Design, and Process Development
Sponsored by:
Co-sponsored by:
Quality by Design in Drug Substance Process Development
Sponsored by:
Co-sponsored by:

Sessions co-sponsored

Crystallization of Pharmaceutical and Biological Molecules
Sponsored by:
Co-sponsored by:
Diagnostics, Treatments and Theranostics
Sponsored by:
Co-sponsored by:
In Honor of Stuart W. Churchill I (Invited Talks)
Sponsored by:
Co-sponsored by:
In Honor of Stuart W. Churchill I (Invited Talks)
Sponsored by:
Co-sponsored by:
In Honor of Stuart W. Churchill II (Invited Talks)
Sponsored by:
Co-sponsored by:
Pharmaceutical Process Development and Pilot Plants
Sponsored by:
Co-sponsored by:
Solid Form Selection: Cocrystals, Salts, Solvates, Polymorphs, and Beyond
Sponsored by:
Co-sponsored by:
Solve this! Fundamental Approach to Problem Solving in Industrial Processes I (Invited Talks)
Sponsored by:
Co-sponsored by:
Solve this! Fundamental Approach to Problem Solving in Industrial Processes II (Invited Talks)
Sponsored by:
Co-sponsored by: